Sana Biotechnology, Inc. (SANA)
$3.78-3.32%Close
BUYRECOVERY · day 15
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $1.1B
- Avg volume
- 3.4M
- Beta
- 2.10
- P/E (TTM)
- -4.97
- Short % float
- 24.26%
- Days to cover
- 16.3
- SI change
- +6.1%
- 1W
- +2.72%
- 1M
- +18.87%
- 3M
- +23.13%
- YTD
- -9.79%
- vs SPY 1W
- +3.91%
- vs SPY 1M
- +15.55%
- vs SPY 3M
- +20.74%
- vs SPY YTD
- -21.54%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- RARESELLUltragenyx Pharmaceutical Inc.RECOVERYQ -1$25.72-0.43%
- BLSMFLATBlossomHill Therapeutics, Inc.Q 16$16.03-2.14%
- RGENBUYRepligen CorporationBULLQ 26$181.62+0.27%
- QTRXSELLQuanterix CorporationCRISISQ -7$2.80-6.35%
- CALCSELLCalciMedica, Inc.CRISISQ -23$0.56-1.75%
- NERVBUYMinerva Neurosciences, Inc.RECOVERYQ 5$4.81-0.62%
- NTHIBUYNeonc Technologies Holdings, Inc.CRISISQ -14$4.69+0.21%
- MTDBUYMettler-Toledo International Inc.BULLQ 26$1398.89+0.26%
- CARLBUYCarlsmed, Inc.RECOVERYQ 17$15.80-1.56%
- TILBUYInstil Bio, Inc.RECOVERYQ -15$7.81+3.03%
- PRCTBUYPROCEPT BioRobotics CorporationRECOVERYQ -1$21.25-1.98%
- BNRBUYBurning Rock Biotech LimitedRECOVERYQ -14$10.32+5.52%
Industry peers
FMP comparable companies · ranked by market cap
- DNTHBUYDianthus Therapeutics, Inc.$6.2BBULLQ 4$111.10-0.93%
- RLAYBUYRelay Therapeutics, Inc.$4.3BBULLQ 4$19.44+1.65%
- NRIXBUYNurix Therapeutics, Inc.$2.8BBULLQ 13$26.72-1.68%
- KODSELLKodiak Sciences Inc.$2.4BCRISISQ 37$38.33-2.90%
- NKTRBUYNektar Therapeutics$2.1BRECOVERYQ 13$74.02-0.45%
- XNCRBUYXencor, Inc.$2.1BBULLQ 17$27.80+4.32%
- SNDXSELLSyndax Pharmaceuticals, Inc.$1.7BRECOVERYQ 18$19.65-0.41%
- INBXBUYInhibrx Biosciences Inc.$1.5BRECOVERYQ 33$103.63+1.26%
- OCSBUYOculis Holding AG$748MRECOVERYQ 5$13.09+0.69%
- PHATSELLPhathom Pharmaceuticals, Inc.$718MCRISISQ 6$8.87-2.37%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 16
- VALUE
- 7
- GROWTH
- 40
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-80.7%
REV YoY-
ROE-134.5%
EPS YoY-
ROA-49.1%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-4.97
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B7.23
P/FCF-
EV/EBITDA-5.32
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E47.71
ALTMAN Z-
CURR RATIO1.38
ND/EBITDA-
BETA2.10








